tanshinone has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, X; Liu, L; Wang, L; Yang, Y; Zhang, X | 1 |
1 other study(ies) available for tanshinone and Chemical and Drug Induced Liver Injury, Chronic
Article | Year |
---|---|
Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2.
Topics: Abietanes; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; Bile Acids and Salts; Chemical and Drug Induced Liver Injury, Chronic; Epigenesis, Genetic; Female; HEK293 Cells; Hepatocytes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Organic Anion Transporters, Sodium-Dependent; Rifampin; Symporters | 2020 |